Conference Posters and Presentations at ASGCT Showcase Utility of Countable PCR in Single Molecule Quantification for Cell and Gene Therapy Applications Proof-of-Concept Assay Services Now Available; Count What Counts Grant Program Will Provide Pilot Study to Selected Cell and Gene Therapy Researcher PALO ALTO, Calif. — Countable Labs, the developer of Countable PCR, the leading […]

CAMBRIDGE, UK – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer, more precise genetic therapies by enabling targeted gene editing, advanced cell engineering, and innovative nucleic acid-based medicines. Built […]

Genovis AB and MGI Tech Co., Ltd. today announce a strengthened collaboration to advance RNA sequencing solutions. The companies have expanded their commercial agreement to integrate Genovis’ SEQURNA reagents with MGI Tech’s high-performance sequencing platforms, enabling researchers to benefit from enhanced RNA preservation and improved sequencing performance. The partnership marks an important step for both […]

DÜSSELDORF, Germany — LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will integrate our ALiCE® platform with Twist’s DNA manufacturing and automation capabilities to accelerate the design–build–test cycle for protein expression services—delivering experimental results back to customers’ and partners’ AI […]

Toronto companies partner to provide an integrated platform that runs the complete clinical genetics workflow, from patient intake to diagnostic report, entirely on Canadian infrastructure. TORONTO, Ontario — DNAstack and PhenoTips today announced an integrated platform that runs clinical genetics workflows, from patient intake and phenotyping to genomic interpretation and diagnostic report, entirely on Canadian infrastructure. At a time […]

Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The […]

Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The […]

Scientists can now design biological experiments, place orders with external lab partners, and receive structured results, without leaving Benchling SAN FRANCISCO — Benchling, the AI platform for biotech R&D, today announced the launch of direct ordering for biological materials and CRO services. This update integrates industry leaders Twist Bioscience for gene synthesis, antibody expression, binding, developability and other […]

Ribbon’s launches Synthetic MiroSynth Cell-Free DNA product manufactured without bacterial cloning steps. The company has also launched the MiroMine kit, allowing customers to create synthetic DNA constructs in their own labs. Together, these announcements represent a step forward in increasing accessibility to complex DNA. VIENNA — Cell-Free DNA assembly company, Ribbon Bio, has today announced two […]

Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA products Complex synthesis capabilities to support further advancement of AI-enabled drug discovery and nucleic acid therapeutics SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, […]